[1] Lange N,Dufour JF.Changing epidemiology of HCC: How to screen and identify patients at risk? Dig Dis Sci,2019,64:903-909.
[2] Jiao Xl,Shu G,Liu H,et al.The Diagnostic value of chemokine/chemokine receptor pairs in hepatocellular carcinoma and colorectal liver metastasis. Histochem Cytochem,2019,67:299-308.
[3] Zhou X,Liao X,Wang Xk,et al.Clinical significance and prospective molecular mechanism of CC motif chemokine receptors in patients with earlystage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.Oncol Rep,2019,42:1856-1868.
[4] Lin SQ,Lv Y,Xu JG,et al.Over-expression of Nav1.6 channels is associated with lymph node metastases in colorectal cancer.World J Surg Oncol,2019,17:175.
[5] Ren FF,Zh QT,Huang L,et al.The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas.Immunol Cell Biol,2019,97:457-469.
[6] Peng WT,Sun WY,Li XR,et al.Emerging roles of G protein-coupled receptors in hepatocellular carcinoma.Int J Mol Sci,2018, 19:1366.
[7] Huijuan BI,Chen J,Chen J,et al.Expressions and clinical significance of CXC chemokine receptor 1 and 2 and CXCL8 in hepatitis B related hepatocellular carcinoma. Chin J Immunol,2017,33: 895-899.
[8] Jiang JH,Ye F,Yang X,et al.Peri-tumor associated fibroblasts promote intrahepatic metastasis of hepatocellular carcinoma by recruiting cancer stem cells.Cancer Lett,2017,404:19-28.
[9] Ding D,Zhang Y,Yang R,et al.miR-940 suppresses tumor cell invasion and migration via regulation of CXCR2 in hepatocellular carcinoma.Bio Med Res Int, 2016,2016:7618342.
[10] Tian H,Huang PX,Zhao ZY,et al. HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression.Cell Physiol Biochem,2014,34:1536-1546.
[11] Hassanin Omayma M,El-Masry Tarek M,El-Baz Ahmed,et al.Association of Interleukin-8 gene polymorphisms and expression with hepatocellular carcinoma in egyptian patients with liver cirrhosis.Egypt J Immunol, 2017,24:143-152.
[12] Wang Y,Yao R,Zhang L,et al.IDO and intra‐tumoral neutrophils were independent prognostic factors for overall survival for hepatocellular carcinoma.J Clin Labor Anal,2019:e22872.
[13] Zhou SL,Yin D,Hu ZQ,et al.A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression.Hepatol,2019,70:1214-1230.
[14] Liu L,Sun H,Wu S,et al.IL17A promotes CXCR2dependent angiogenesis in a mouse model of liver cancer.Mol Med Rep,2019,1065-1074.
[15] Lee S Y,Jung W,Lee J,et al.High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.Histol Histopathol,2019:18125.
[16] Capitano M L,Mor-Vaknin N,Saha A K,et al.Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.J Clin Invest, 2019,130:2555.
[17] Li YM,Liu ZY,Wang JC,et al.RIP 3 deficiency recruits myeloid‐derived suppressor cells to hepatocellular carcinoma through the CXCL 1‐CXCR 2 axis. Hepatol,2019.
[18] Jiang W,Li Y,Li ZZ,et al.Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing splenic myeloid cells through activating β-adrenergic signaling.Brain Behav Immun,2019,80:825-838.
[19] Han X,Shi H,Sun Y,et al.CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3.Cell Death Dis,2019,10:598.
[20] Saraswati S,Alhaider A,Abdelgadir AM,et al. Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.Cell Commun Signal,2019,17:127.
[21] Zheng YW,Ma MZ,Xu YT,et al.CXCL6 is upregulated in hepatocellular carcinoma and promotes invasion of liver cancer cells via targeting MMP9.Int J Clin Exp Pathol,2016,9:4661.
[22] Zhou SL,Zhou ZJ,Hu ZQ,et al.CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.Cancer Lett,2015,358:124-135.
[23] Lu Y,Li S,Ma L,et al.Type conversion of secretomes in a 3D TAM2 and HCC cell co-culture system and functional importance of CXCL2 in HCC.Sci Rep,2016,6:24558.
[24] Wang S,Yang FJ,Wang X,et al.PARP-1 promotes tumor recurrence after warm ischemic liver graft transplantation via neutrophil recruitment and polarization.Oncotarget,2017, 8:88918.
[25] Bi H,Zhang Y,Wang S,et al.Interleukin8 promotes cell migration via CXCR1 and CXCR2 in liver cancer.Oncol Lett,2019,18:4176-4184.
[26] Sun F,Wang J,Sun Q,et al.Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma.J Exp Clin Can Res,2019,38:1-10.
[27] Feng W,Xue T,Huang S,et al.HIF-1α promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8-NF-κB axis.Cell Mol Bio Lett,2018,23:26.
[28] Cui ZY,Jo E,Jang HJ,et al.Modified ginseng extract induces apoptosis in hepg2 cancer cells by blocking the cxcl8-mediated akt/nuclear factor-κb signaling pathway. Am J Chin Med,2018,46:1645-1662.
[29] Chen X,Liu L,Wang JJ,et al.CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma.Urol Oncol, 2018,36:242.
[30] Odagiri N,Matsubara T,Higuchi M,et al.Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells.Mol Cell Biochem,2019,455:7-19.
[31] Xi Y,Qi Z,Ma J,et al.PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells. Clin Exp Metast,2019:1-13.
[32] Meng YM,Liang J,Wu C,et al.Monocytes/macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma.Oncoimmunology,2018,7:e1408745.
[33] Zhong J,Li JX,Wei JX,et al.Plumbagin restrains hepatocellular carcinoma angiogenesis by stromal cell-derived factor (SDF-1)/CXCR4-CXCR7 axis.Med Sci Monit,2019, 25:6110-6119. |
